GLP-1 Weight Loss
Gala GLP-1 Review: The Most Affordable Path to Semaglutide and Tirzepatide
Best Overall, Most Affordable
At a Glance
- Best for
- Women who want effective GLP-1 treatment without the $1,000+ monthly retail price tag
- Starting price
- $129/mo
- Editor score
- 9.4/10
Overview
For women researching GLP-1 weight loss in 2026, the single biggest barrier is no longer access. It is price. Brand-name Wegovy, Ozempic, and Zepbound regularly clear $1,000 a month at retail, and even with insurance the out-of-pocket cost can be punishing. Gala has built its entire program around fixing that. Compounded Semaglutide starts at $129 a month on the annual plan, and compounded Tirzepatide starts at $179 a month, which is a fraction of what a brand-name prescription typically costs.
Gala is not the only telehealth program offering compounded GLP-1 medications, but in our review it was the most consistent on the variables that actually matter: published pricing, provider quality, and the speed at which you can go from intake to medication delivery. After scoring it against eleven other programs, Gala took the top spot in our 2026 ranking.
At a Glance
| Pricing | From $129/mo (Semaglutide), $179/mo (Tirzepatide) |
| Medications | Compounded Semaglutide, compounded Tirzepatide |
| Provider | Licensed clinicians, fully online |
| Delivery | Free shipping with annual plan |
| Cancellation | Cancel any time |
| Discount code | GALA12 (save up to $1,440 over a year) |
How It Works
- Online assessment. You complete a medical intake online. Gala asks the same kinds of questions a clinician would ask in person, including weight history, current medications, and any GI history.
- Provider review. A licensed clinician reviews your assessment and decides whether GLP-1 treatment is appropriate. If you are not a candidate, Gala does not charge you for the medication.
- Medication shipped. If you are approved, your compounded medication is shipped directly to your door from a partner pharmacy. Annual plan members get free shipping and the lowest pricing.
The whole flow takes about a week from intake to first dose for most patients, with no office visits required.
Pricing Breakdown
Gala’s pricing structure is the cleanest we found. There are two products, and the pricing is published, not hidden behind an account creation wall.
| Plan | Annual price | What you get |
|---|---|---|
| Semaglutide, annual | $129/mo | Compounded Semaglutide, provider review, ongoing care |
| Tirzepatide, annual | $179/mo | Compounded Tirzepatide, provider review, ongoing care |
The discount code GALA12 is currently active and applies to new patients. Gala publishes that the code can save up to $1,440 over a year, which lines up with our math when stacked on the annual plan.
For comparison, brand-name Wegovy is widely listed at $1,349 per month in the U.S. without insurance. A reader paying retail for brand-name medication for a full year could pay roughly $16,000. The same year on Gala’s annual Semaglutide plan with the GALA12 code is closer to $1,500. That is the gap that makes Gala worth a serious look.
The Hormone Science
Most weight loss frameworks frame willpower as the variable. GLP-1 medications change a different variable: the hormone signal. GLP-1 (glucagon-like peptide-1) is a hormone your gut already releases after meals, and it is one of the signals that tells your brain you are full. GLP-1 medications mimic that signal at a steadier level. The result is reduced appetite, slower gastric emptying, and a quieter version of the food noise that drives a lot of weight regain. Gala’s positioning leans into this clearly: the program treats weight as a hormonal signal, not a character flaw.
Pros
- Lowest entry price we found for a credible compounded Semaglutide program
- Both Semaglutide and Tirzepatide options under one provider
- Provider-reviewed treatment with no in-person visits
- Free shipping with the annual plan
- Active discount code (GALA12) that meaningfully lowers the annual cost
Cons
- The lowest published prices require an annual commitment, not month-to-month
- Compounded medications are not FDA-approved (a category-wide limitation, not Gala-specific)
- Mild nausea in the first weeks is a common report, consistent with GLP-1 medications generally
Who It’s For
Gala is the right fit for women who have already concluded that GLP-1 treatment is worth trying and are looking for the most efficient path to it. If price is the main thing standing between you and trying GLP-1 care, Gala removes that obstacle better than any program in our 2026 review. It is also a strong fit if you want both Semaglutide and Tirzepatide options under one provider, in case you want to switch protocols later.
Who Should Skip
Gala is probably not the right fit if you specifically want a brand-name medication like Wegovy or Zepbound. Those are not what Gala offers. It is also not the right fit if you have a history of severe gastrointestinal disease or pancreatitis, both of which are flagged for additional caution with GLP-1 medications. In those cases an in-person workup with a clinician who knows your history is the safer first step.
Side Effects and Safety
The most commonly reported side effects on GLP-1 medications are mild gastrointestinal: nausea, occasional reflux, and slower digestion in the first few weeks. For most patients, these settle as the body adjusts to the medication, and providers can adjust the dose if symptoms persist. Gala’s clinical team handles dose escalation conservatively, which lines up with current best practice in the GLP-1 category.
That said, GLP-1 medications are not a fit for everyone. People with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 should not take GLP-1 receptor agonists. People with a history of pancreatitis, severe GI motility issues, or active gallbladder disease should consult their primary care physician before starting. Gala’s intake screens for these, but readers should still surface their full medical history.
Bottom Line
Gala is the program we would recommend to a friend asking how to start GLP-1 treatment without taking on a $1,000-a-month bill. The pricing is clean, the provider experience is real, and the medication options cover most of what a typical GLP-1 patient would want. The trade-off is the annual commitment for the lowest price, and the fact that compounded medications are not FDA-approved. Those are real considerations, but neither is unique to Gala, and both are reasonable trade-offs for the cost difference.
If you are weighing Gala against a brand-name program through a generic telehealth platform, the math is hard to argue with. For the women’s GLP-1 use case in 2026, Gala is the program that does the most for the least money, and that is why it is our 2026 pick for Best Overall.
Final Score Breakdown
| Category | Score |
|---|---|
| Affordability | 9.8 |
| Provider Quality | 9.0 |
| User Experience | 9.5 |
| Customer Support | 9.2 |
| Overall | 9.4 |
Try Gala
If you want to see whether Gala is a fit, the next step is the online medical assessment. It takes about a minute and a licensed provider reviews your answers before any medication is prescribed.
Start your Gala assessment
Use code GALA12 at checkout to save up to $1,440 over a year on the annual plan.